Syensqo SA/NV | SYENS Logo | Annual Report & Investor Relations Data

Syensqo SA/NV | SYENS - Annual Report & Investor Relations Data

Syensqo SA/NV | SYENS
Annual Report & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Ticker

SYENS

Sector

Health Care

Industry

Pharmaceuticals

Country

Belgium

Year Founded

2023

Syensqo SA/NV (SYENS)

About Syensqo SA/NV

At Syensqo, we’re explorers: experts in science and passionate about all its possibilities. Our innovative products and solutions help enhance the way people around the world live life every day: how they work, travel, and spend leisure time.

Inspired by the legacy of the Solvay Congresses, which brought together the greatest scientific minds to explore answers to the world’s biggest challenges, we strive to break new ground: addressing the critical needs of today and creating solutions for the future. We’re constantly expanding on what’s seemingly impossible and pushing the limits of what can be realized.

With a diverse global team of more than 13,000 employees in 30 countries, we work together to advance science and help humanity move forward.

Employees

13,000

Market Presence

Worldwide

Headquarters

RUE DE LA FUSÉE 98
1130, BRUSSELS
Belgium

Company Video

Video thumbnail
Click to load video from YouTube

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Syensqo SA/NV (SYENS)
Filings & Annual Reports

Filters

View all types
Filing Information Actions

Insider Trading Activity

Person (Position) Type Volume Price Date
Roger Davis Christopher (Board)
Buy EUR 48,795.78 EUR 55.77 09.04.25
Kadri Ilham (Board)
Buy EUR 0.00 EUR 0.00 01.04.25
Roger Davis Christopher (Board)
Buy EUR 0.00 EUR 0.00 31.03.25
Tiberghien Hervé (Board)
Buy EUR 0.00 EUR 0.00 24.03.25
Chollet Marc (Board)
Buy EUR 0.00 EUR 0.00 23.03.25
Tiberghien Hervé (Board)
Sell EUR 236,451.96 EUR 68.48 03.03.25
Chollet Marc (Board)
Sell EUR 234,192.20 EUR 68.48 03.03.25
Roger Davis Christopher (Board)
Buy EUR 49,689.07 EUR 69.99 28.02.25
Roger Davis Christopher (Board)
Buy EUR 50,184.00 EUR 69.70 23.12.24
Meaney Haynes Mary (Board)
Buy EUR 40,128.17 EUR 74.55 15.11.24

Syensqo SA/NV (SYENS)
Stock & Investor Information

ISINs

BE0974464977
BE6282460615
BE6324000858
BE6352831109

LEI

549300060XNJ90PLNS10

Stock Exchange Listings

Euronext Brussels

Stock Index

STOXX Europe 600

Industry Classification

Syensqo SA/NV (SYENS)
Related Companies & Peer Group

ABIVAX Logo

ABIVAX

ABVX

Sector

Health Care

Country

France

ISIN

FR0012333284

Founded

Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …

Addex Therapeutics Ltd Logo

Addex Therapeutics Ltd

ADXN

Sector

Health Care

Country

Switzerland

ISIN

CH0029850754

Founded

2002

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …

AegirBio AB Logo

AegirBio AB

AEGIR

Sector

Health Care

Country

Sweden

ISIN

SE0014401121

Founded

2019

AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …

AGRONOMICS LIMITED Logo

AGRONOMICS LIMITED

ANIC

Sector

Health Care

Country

Isle of Man

ISIN

Founded

Allergy Therapeutics PLC: Global immunology leader, researching, developing, and manufacturing convenient allergy treatments.Ê Our mission: Transforming lives through innovative immunotherapy.

AIREA PLC Logo

AIREA PLC

AIEA

Sector

Health Care

Country

United Kingdom

ISIN

Founded

Alliance Pharma PLC improves lives through clinically valuable healthcare products. We market consumer & prescription medicines, leveraging an asset-light model …

Alkaloid AD Logo

Alkaloid AD

ALK

Sector

Health Care

Country

North Macedonia

ISIN

MKALKA101011

Founded

1936

Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …